GeneDx
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $102,692 | $87,115 | $95,640 | $76,874 |
Gross Profit | 70,902 | 58,476 | 66,205 | 47,829 |
EBITDA | 17,571 | -4,551 | 11,670 | -1,851 |
EBIT | 11,380 | -6,722 | 6,112 | -7,780 |
Net Income | 10,809 | -6,529 | 5,438 | -8,312 |
Net Change In Cash | 102,692 | 87,115 | 95,640 | 76,874 |
Free Cash Flow | 13,030 | 4,053 | -6,233 | -5,041 |
Cash | 74,120 | 99,704 | 85,212 | 57,894 |
Basic Shares | 29,753 | 28,147 | 26,993 | 27,095 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $305,450 | $202,566 | $234,694 | $212,195 |
Gross Profit | 194,397 | 60,622 | -26,750 | -16,602 |
EBITDA | -27,644 | -136,460 | -398,198 | -219,193 |
EBIT | -49,597 | -170,194 | -457,507 | -242,555 |
Net Income | -52,286 | -175,767 | -548,980 | -245,390 |
Net Change In Cash | 305,450 | 202,566 | 234,694 | 212,195 |
Free Cash Flow | -33,987 | -185,858 | -333,477 | -211,220 |
Cash | 85,212 | 99,681 | 123,933 | 400,569 |
Basic Shares | 26,891 | 24,311 | 10,236 | 3,275 |
